Risk of Nonunion Associated with NSAID Use Following Partial Wrist Fusion: A Retrospective Analysis

Abstract

Introduction

The purpose of this investigation was to assess whether the use of nonselective nonsteroidal anti-inflammatory drugs (NSAIDs) or selective cyclooxygenase-2 (COX-2) inhibitors in the perioperative period is associated with the risk of nonunion after partial wrist fusion. We hypothesized that exposure to nonselective NSAIDs or selective COX-2 inhibitors would not increase the rate of nonunion after partial wrist fusion when compared with control cohorts.

Materials and Methods

The TriNetX U.S. Collaborative database was queried using Current Procedural Terminology (CPT) and International Classification of Diseases, 10th Revision (ICD-10) codes to identify patients aged 18 and older who underwent partial wrist fusion between 2008 and 2023. Patients were stratified according to the chronicity and type of NSAID use, including chronic NSAID use (within 90 days of surgery), acute NSAID use (within 30 days of surgery), perioperative ketorolac (Toradol) use (within 24 hours of surgery), and selective COX-2 inhibitor use (within 30 days of surgery). The cohorts were propensity-matched by age, gender, race, ethnicity, body mass index (BMI; kg/m²), and presence of type 2 diabetes mellitus. The risk of nonunion, defined as the need for revision fusion, conversion to total wrist arthrodesis, or conversion to total wrist arthroplasty, was assessed within the 1-year postoperative period. Chi-square analyses were used to compare the rate of nonunion for each cohort. Statistical significance was determined to be a p-value <0.05.

Results

A total of 3,073 patients undergoing partial wrist fusion were identified, of which 2,072 had a documented history of perioperative NSAID use. After 1:1 propensity score matching, the cohorts included 1,148 patients in the chronic NSAID group, 889 in the acute NSAID group, 482 in the Toradol group, and 140 in the COX-2 inhibitor group. The rate of nonunion was significantly higher in patients exposed to NSAIDs within 30 days of surgery (5.96%) compared with the control cohort (3.04%; p = 0.003). However, chronic exposure to NSAIDs or perioperative Toradol was not associated with a higher rate of nonunion (p = 0.17 and p = 0.56, respectively). Additionally, use of selective COX-2 inhibitors versus nonselective COX-2 inhibitors had no significant impact on the rate of nonunion (p = 0.66).

Conclusion

Patients exposed to NSAIDs within 30 days of a partial wrist fusion had an increased risk of nonunion when compared with a control cohort. Acute use of NSAIDs may be a risk factor for impaired bone healing after partial wrist fusion, and their use should be carefully considered in high-risk patients.

Keywords

partial wrist arthrodesis - four-corner fusion - nonsteroidal anti-inflammatory drugs - selective COX-2 inhibitors - nonunion

• References

• 1 Hayes E, Cheng Y, Sauder D, Sims L. Four-corner arthrodesis with differing methods of osteosynthesis: A systematic review. J Hand Surg Am 2022; 47 (05) 477.e1-477.e9
• 2 Watson HK, Ballet FL. The SLAC wrist: Scapholunate advanced collapse pattern of degenerative arthritis. J Hand Surg Am 1984; 9 (03) 358-365
• 3 Erne HC, Broer PN, Weiss F. et al. Four-corner fusion: Comparing outcomes of conventional K-wire-, locking plate-, and retrograde headless compression screw fixations. J Plast Reconstr Aesthet Surg 2019; 72 (06) 909-917
• 4 d'Almeida MA, Sturbois-Nachef N, Amouyel T, Chantelot C, Saab M. Four-corner fusion: Clinical and radiological outcome after fixation by headless compression screws or dorsal locking plate at minimum 5 years' follow-up. Orthop Traumatol Surg Res 2021; 107 (05) 102886
• 5 Hundepool CA, Duraku LS, Quanjel TJM, van Minnen LP, Jansen MC, Zuidam JM. Two-, three-, or four-corner arthrodesis for midcarpal osteoarthritis: A systematic review and meta-analysis. J Hand Surg Am 2025; 50 (01) 93.e1-93.e11
• 6 Hones KM, Hao KA, Rakauskas TR. et al. Four-corner fusion versus proximal row carpectomy for scapholunate advanced collapse and scaphoid nonunion advanced collapse wrist: A systematic review and meta-analysis. J Hand Surg Am 2024; 49 (07) 633-638
• 7 Dunn JC, Polmear MM, Scanaliato JP, Orr JD, Nesti LJ. Capitolunate arthrodesis: A systematic review. J Hand Surg Am 2020; 45 (04) 365.e1-365.e10
• 8 Mantovani G, Mathoulin C, Fukushima WY, Cho AB, Aita MA, Argintar E. Four corner arthrodesis limited to the centre using a scaphoid one piece graft and a dorsal circular plate. J Hand Surg Eur Vol 2010; 35 (01) 38-42
• 9 Pountos I, Georgouli T, Calori GM, Giannoudis PV. Do nonsteroidal anti-inflammatory drugs affect bone healing? A critical analysis. ScientificWorldJournal 2012; 2012: 606404
• 10 Wheatley BM, Nappo KE, Christensen DL, Holman AM, Brooks DI, Potter BK. Effect of NSAIDs on bone healing rates: A meta-analysis. J Am Acad Orthop Surg 2019; 27 (07) e330-e336
• 11 Hsu JR, Mir H, Wally MK, Seymour RB. Orthopaedic Trauma Association Musculoskeletal Pain Task Force. Clinical practice guidelines for pain management in acute musculoskeletal injury. J Orthop Trauma 2019; 33 (05) e158-e182
• 12 Chuang PY, Yang TY, Tsai YH, Huang KC. Do NSAIDs affect bone healing rate, delay union, or cause non-union: an updated systematic review and meta-analysis. Front Endocrinol (Lausanne) 2024; 15: 1428240
• 13 TriNetX. Home page. Accessed January 7, 2025 at: https://live.trinetx.com/
• 14 Palchuk MB, London JW, Perez-Rey D. et al. A global federated real-world data and analytics platform for research. JAMIA Open 2023; 6 (02) ooad035
• 15 Lu LY, Loi F, Nathan K. et al. Pro-inflammatory M1 macrophages promote Osteogenesis by mesenchymal stem cells via the COX-2-prostaglandin E2 pathway. J Orthop Res 2017; 35 (11) 2378-2385
• 16 Gerstenfeld LC, Al-Ghawas M, Alkhiary YM. et al. Selective and nonselective cyclooxygenase-2 inhibitors and experimental fracture-healing. Reversibility of effects after short-term treatment. J Bone Joint Surg Am 2007; 89 (01) 114-125
• 17 Simon AM, Manigrasso MB, O'Connor JP. Cyclo-oxygenase 2 function is essential for bone fracture healing. J Bone Miner Res 2002; 17 (06) 963-976
• 18 George MD, Baker JF, Leonard CE, Mehta S, Miano TA, Hennessy S. Risk of nonunion with nonselective NSAIDs, COX-2 inhibitors, and opioids. J Bone Joint Surg Am 2020; 102 (14) 1230-1238
• 19 Kim H, Kim DH, Kim DM. et al. Do nonsteroidal anti-inflammatory or COX-2 inhibitor drugs increase the nonunion or delayed union rates after fracture surgery?: A propensity-score-matched study. J Bone Joint Surg Am 2021; 103 (15) 1402-1410
• 20 Zhang X, Schwarz EM, Young DA, Puzas JE, Rosier RN, O'Keefe RJ. Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair. [published correction appears in J Clin Invest 2002 Oct;110(8):1211] J Clin Invest 2002; 109 (11) 1405-1415
• 21 O'Connor JP, Capo JT, Tan V. et al. A comparison of the effects of ibuprofen and rofecoxib on rabbit fibula osteotomy healing. Acta Orthop 2009; 80 (05) 597-605
• 22 Gerstenfeld LC, Thiede M, Seibert K. et al. Differential inhibition of fracture healing by non-selective and cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs. J Orthop Res 2003; 21 (04) 670-675
• 23 Beck A, Krischak G, Sorg T. et al. Influence of diclofenac (group of nonsteroidal anti-inflammatory drugs) on fracture healing. Arch Orthop Trauma Surg 2003; 123 (07) 327-332
• 24 Andronic O, Nagy L, Burkhard MD. et al. Long-term outcomes of the four-corner fusion of the wrist: A systematic review. World J Orthop 2022; 13 (01) 112-121
• 25 Chang M, Kasper A, Chung J, Wright J, Pennington M, Ilyas AM. The effect of nonsteroidal anti-inflammatory drugs on union rates following operative repair of distal radius fractures. J Hand Surg Glob Online 2025; 7 (04) 100720